The US has imposed a 100% tariff on branded and patented pharmaceuticals, targeting imports from India’s $10 billion export industry. While generics remain unaffected for now, uncertainty persists around complex drugs. Sun Pharma, Dr. Reddy’s, Cipla, and Zydus face the highest risks due to significant US revenue exposure.Read More

Bitcoin experienced a dip, trading around $109,506, reflecting market caution despite a bullish long-term outlook fueled by supply reduction and institutional interest. Ethereum, XRP and Solana also saw declines. Market experts suggest upcoming macro releases and the $22 billion monthly options expiry could further influence volatility. Spot buyers are stepping in, indicating long-term conviction remains...Read More

Hindustan Aeronautics Limited shares are soaring. This follows a major contract from the Defence Ministry for 97 Light Combat Aircraft Mk1A. Analysts predict further stock gains. The deal is worth over Rs 62,370 crore. Deliveries are expected to start in FY28. The aircraft will have over 64% indigenous content. This project will boost India’s domestic...Read More

Tata Motors faced concerns after a cyber attack impacted JLR, but an expert suggests the situation is stabilizing. GST cuts in India and a potential US-UK trade pact could boost the company’s prospects. While cautious about the H-1B visa debate’s impact on technology, the expert sees long-term potential in defense stocks like Bharat Electronics, despite...Read More

Nazara Technologies shares appeared to fall 75% on September 26 due to a simultaneous 1:2 stock split and 1:1 bonus issue. Each share effectively converted into four, lowering the price proportionally while keeping overall investment value unchanged and boosting liquidity for investors.Read More

President Trump’s imposition of 100% tariffs on branded drugs has shaken Indian pharma companies, impacting stocks like Sun Pharma, Cipla, and Dr. Reddy’s. With significant US revenue exposure, firms face potential earnings hits, especially if tariffs expand to complex generics. Companies with US manufacturing plants may find some mitigation, but uncertainty looms over the future...Read More

Post ContentRead More

Epack Prefab Technologies’ IPO is trading at a grey market premium of roughly 6.8% (₹14), indicating moderate investor interest. The shares are likely to list near ₹218 based on the current GMP.Read More

Tata Motors shares rose on September 26 as Jaguar Land Rover (JLR) began a phased restart after a cyberattack halted production for nearly a month. Operations, IT systems, and logistics are being restored, aiming to clear backlogs and stabilise revenue impact.Read More

U.S. markets are navigating a complex landscape of new tariffs, a thriving AI sector, and revised economic data, creating investor uncertainty. Peter Cardillo suggests the announced pharmaceutical tariffs are a negotiation tactic, while AI continues to attract significant investment. He cautions against overemphasizing strong GDP figures, citing unusual trade flows, and highlights inflation as a...Read More